Anna Suleri1, Elisabet Blok1, Melisa Durkut1, Anna-Sophie Rommel2, Lot de Witte2, Vincent Jaddoe3, Veerle Bergink4, Tonya White5. 1. Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, The Netherlands; The Generation R Study Group, Erasmus University Medical Centre, Rotterdam, The Netherlands. 2. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. 3. The Generation R Study Group, Erasmus University Medical Centre, Rotterdam, The Netherlands; Department of Pediatrics, Erasmus University Medical Centre, Rotterdam, The Netherlands. 4. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA; Department of Psychiatry, Erasmus University Medical Centre, Rotterdam, The Netherlands. 5. Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, The Netherlands. Electronic address: t.white@erasmusmc.nl.
Abstract
IMPORTANCE: Animal studies show that Maternal Immune Activation (MIA) may have detrimental effects on fetal brain development. Clinical studies provide evidence for structural brain abnormalities in human neonates following MIA, but no study has investigated the long-term effects of MIA (as measured with biomarkers) on human brain morphology ten years after the exposure. OBJECTIVE: Our aim was to evaluate the long-term impact of MIA on brain morphology in 10-year-old children, including the possible mediating role of gestational age at birth. DESIGN: We leveraged data from Generation R, a large-scale prospective pregnancy cohort study. Pregnant women were included between 2002 and 2006, and their children were invited to participate in the MRI study between 2013 and 2015. To be included, mother-child dyads had to have data on maternal C-reactive protein levels during gestation and a good quality MRI-scan of the child's brain at age 10 years. Of the 3,992 children scanned, a total of 2,053 10-year-old children were included in this study. EXPOSURE: Maternal C-reactive protein was measured in the first 18 weeks of gestation. For the analyses we used both a continuous approach as well as a categorical approach based on clinical cut-offs to determine if there was a dose-response relationship. MAIN OUTCOMES AND MEASURES: High-resolution MRI brain morphology measures were used as the primary outcome. Gestational age at birth, established using ultrasound, was included as a mediator using a causal mediation analysis. Corrections were made for relevant confounders and multiple comparisons. Biological sex was investigated as moderator. RESULTS: We found a direct association between continuous MIA and lower cerebellar volume. In girls, we demonstrated a negative indirect association between continuous MIA and total brain volume, through the mediator gestational age at birth. We observed no associations with categorical MIA after multiple testing correction. CONCLUSION AND RELEVANCE: Our results suggest sex-specific long-term effects in brain morphology after MIA. Categorical analyses suggest that this association might be driven by acute infections or other sources of severe inflammation, which is of clinical relevance given that the COVID-19 pandemic is currently affecting millions of pregnant women worldwide.
IMPORTANCE: Animal studies show that Maternal Immune Activation (MIA) may have detrimental effects on fetal brain development. Clinical studies provide evidence for structural brain abnormalities in human neonates following MIA, but no study has investigated the long-term effects of MIA (as measured with biomarkers) on human brain morphology ten years after the exposure. OBJECTIVE: Our aim was to evaluate the long-term impact of MIA on brain morphology in 10-year-old children, including the possible mediating role of gestational age at birth. DESIGN: We leveraged data from Generation R, a large-scale prospective pregnancy cohort study. Pregnant women were included between 2002 and 2006, and their children were invited to participate in the MRI study between 2013 and 2015. To be included, mother-child dyads had to have data on maternal C-reactive protein levels during gestation and a good quality MRI-scan of the child's brain at age 10 years. Of the 3,992 children scanned, a total of 2,053 10-year-old children were included in this study. EXPOSURE: Maternal C-reactive protein was measured in the first 18 weeks of gestation. For the analyses we used both a continuous approach as well as a categorical approach based on clinical cut-offs to determine if there was a dose-response relationship. MAIN OUTCOMES AND MEASURES: High-resolution MRI brain morphology measures were used as the primary outcome. Gestational age at birth, established using ultrasound, was included as a mediator using a causal mediation analysis. Corrections were made for relevant confounders and multiple comparisons. Biological sex was investigated as moderator. RESULTS: We found a direct association between continuous MIA and lower cerebellar volume. In girls, we demonstrated a negative indirect association between continuous MIA and total brain volume, through the mediator gestational age at birth. We observed no associations with categorical MIA after multiple testing correction. CONCLUSION AND RELEVANCE: Our results suggest sex-specific long-term effects in brain morphology after MIA. Categorical analyses suggest that this association might be driven by acute infections or other sources of severe inflammation, which is of clinical relevance given that the COVID-19 pandemic is currently affecting millions of pregnant women worldwide.
Authors: Layla L de Jonge; Eric A P Steegers; Gesina D S Ernst; Jan Lindemans; Henk Russcher; Albert Hofman; Vincent W V Jaddoe Journal: J Hypertens Date: 2011-12 Impact factor: 4.844
Authors: Sharon K Hunter; M Camille Hoffman; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman; Amanda J Law Journal: Psychol Med Date: 2019-12-02 Impact factor: 7.723
Authors: Tonya White; Ryan L Muetzel; Hanan El Marroun; Laura M E Blanken; Philip Jansen; Koen Bolhuis; Desana Kocevska; Sabine E Mous; Rosa Mulder; Vincent W V Jaddoe; Aad van der Lugt; Frank C Verhulst; Henning Tiemeier Journal: Eur J Epidemiol Date: 2017-10-24 Impact factor: 8.082
Authors: Veronika Kana; Fiona A Desland; Maria Casanova-Acebes; Pinar Ayata; Ana Badimon; Elisa Nabel; Kazuhiko Yamamuro; Marjolein Sneeboer; I-Li Tan; Meghan E Flanigan; Samuel A Rose; Christie Chang; Andrew Leader; Hortense Le Bourhis; Eric S Sweet; Navpreet Tung; Aleksandra Wroblewska; Yonit Lavin; Peter See; Alessia Baccarini; Florent Ginhoux; Violeta Chitu; E Richard Stanley; Scott J Russo; Zhenyu Yue; Brian D Brown; Alexandra L Joyner; Lotje D De Witte; Hirofumi Morishita; Anne Schaefer; Miriam Merad Journal: J Exp Med Date: 2019-07-26 Impact factor: 14.307
Authors: Hanan El Marroun; Runyu Zou; Michelle F Leeuwenburg; Eric A P Steegers; Irwin K M Reiss; Ryan L Muetzel; Steven A Kushner; Henning Tiemeier Journal: JAMA Pediatr Date: 2020-12-01 Impact factor: 16.193
Authors: Pinar Ayata; Ana Badimon; Hayley J Strasburger; Mary Kaye Duff; Sarah E Montgomery; Yong-Hwee E Loh; Anja Ebert; Anna A Pimenova; Brianna R Ramirez; Andrew T Chan; Josefa M Sullivan; Immanuel Purushothaman; Joseph R Scarpa; Alison M Goate; Meinrad Busslinger; Li Shen; Bojan Losic; Anne Schaefer Journal: Nat Neurosci Date: 2018-07-23 Impact factor: 24.884